Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades Preferred Bank to Market Perform

Raymond James Downgrades Preferred Bank to Market Perform

Raymond James analyst David Feaster downgrades Preferred Bank (NASDAQ:PFBC) from Outperform to Market Perform.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Raymond James analyst David Feaster downgrades Preferred Bank (NASDAQ:PFBC) from Outperform to Market Perform.

Here’s How Much You Would Have Made Owning Kroger Stock In The Last 15 Years

By Benzinga Insights

December 27, 4:32 PM

Kroger (NYSE:KR) has outperformed the market over the past 15 years by 2.21% on an annualized basis producing…

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia

By Rolando García

June 5, 9:12 PM

Canada Magic Mushrooms and MDMA market is hitting new milestones as canada has licensed Optimi to export psilocybin and MDMA to Australia

LULU

Keybanc Upgrades Avid Bioservices to Overweight, Announces $20 Price Target

By Benzinga Newsdesk

March 14, 5:00 AM

Keybanc analyst Paul Knight upgrades Avid Bioservices (NASDAQ:CDMO) from Sector Weight to Overweight and announces $20 price target.

CDMO

Cryo-Cell International Q2 EPS $0.08 Down From $0.14 YoY, Sales $7.63M Up From $7.21M YoY

By Bill Haddad

July 11, 4:32 PM

Cryo-Cell International (NASDAQ:CCEL) reported quarterly earnings of $0.08 per share. This is a 42.86 percent decrease over earnings of $0.14 per share from the same period last year. The company reported $7.63 million

CCEL

Raymond James Downgrades Preferred Bank to Market Perform

Related Posts

Here’s How Much You Would Have Made Owning Kroger Stock In The Last 15 Years

New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia

Keybanc Upgrades Avid Bioservices to Overweight, Announces $20 Price Target

Cryo-Cell International Q2 EPS $0.08 Down From $0.14 YoY, Sales $7.63M Up From $7.21M YoY